IL165240A0 - Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemorsistance - Google Patents

Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemorsistance

Info

Publication number
IL165240A0
IL165240A0 IL16524003A IL16524003A IL165240A0 IL 165240 A0 IL165240 A0 IL 165240A0 IL 16524003 A IL16524003 A IL 16524003A IL 16524003 A IL16524003 A IL 16524003A IL 165240 A0 IL165240 A0 IL 165240A0
Authority
IL
Israel
Prior art keywords
chemorsistance
predict
gene expression
differential patterns
chemosensitivity
Prior art date
Application number
IL16524003A
Other languages
English (en)
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of IL165240A0 publication Critical patent/IL165240A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16524003A 2002-05-17 2003-05-16 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemorsistance IL165240A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38114102P 2002-05-17 2002-05-17
PCT/US2003/015691 WO2004035805A2 (en) 2002-05-17 2003-05-16 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemoresistance

Publications (1)

Publication Number Publication Date
IL165240A0 true IL165240A0 (en) 2005-12-18

Family

ID=32107802

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16524003A IL165240A0 (en) 2002-05-17 2003-05-16 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemorsistance

Country Status (10)

Country Link
US (1) US20040018527A1 (de)
EP (1) EP1576177A4 (de)
JP (1) JP2006505256A (de)
AU (1) AU2003301458A1 (de)
CA (1) CA2486105A1 (de)
IL (1) IL165240A0 (de)
MX (1) MXPA04011424A (de)
RU (1) RU2004136990A (de)
WO (1) WO2004035805A2 (de)
ZA (1) ZA200409189B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465542B2 (en) * 2002-10-15 2008-12-16 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining risk of treatment toxicity
EP1759009A1 (de) * 2004-05-28 2007-03-07 Board Of Regents, The University Of Texas System Multigen-prädiktoren der reaktion auf chemotherapie
JP5299885B2 (ja) * 2005-08-12 2013-09-25 学校法人日本大学 Hcv陽性肝細胞癌の発癌・再発に関連する遺伝子
US20080085243A1 (en) * 2006-10-05 2008-04-10 Sigma-Aldrich Company Molecular markers for determining taxane responsiveness
JPWO2011065533A1 (ja) * 2009-11-30 2013-04-18 国立大学法人大阪大学 乳癌術前化学療法に対する感受性の判定方法
WO2011124669A1 (en) 2010-04-08 2011-10-13 Institut Gustave Roussy Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family
KR102737876B1 (ko) * 2021-12-01 2024-12-06 재단법인 아산사회복지재단 유방암 환자의 선행 항암화학요법 후 예후 예측을 위한 바이오마커 및 이의 용도

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5119827A (en) * 1990-09-05 1992-06-09 Board Of Regents, The University Of Texas System Mechanisms of antiestrogen resistance in breast cancer
US5645988A (en) * 1991-05-08 1997-07-08 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying drugs with selective effects against cancer cells
HK1004920A1 (en) * 1993-01-21 1998-12-11 President And Fellows Of Harvard College Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
US6136587A (en) * 1995-07-10 2000-10-24 The Rockefeller University Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
US20020006613A1 (en) * 1998-01-20 2002-01-17 Shyjan Andrew W. Methods and compositions for the identification and assessment of cancer therapies
US6107034A (en) * 1998-03-09 2000-08-22 The Board Of Trustees Of The Leland Stanford Junior University GATA-3 expression in human breast carcinoma
US6203987B1 (en) * 1998-10-27 2001-03-20 Rosetta Inpharmatics, Inc. Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
US6759238B1 (en) * 1999-03-31 2004-07-06 St. Jude Children's Research Hospital Multidrug resistance associated proteins and uses thereof
WO2001051667A2 (en) * 2000-01-14 2001-07-19 Integriderm, L.L.C. Informative nucleic acid arrays and methods for making same
AU2001245295A1 (en) * 2000-02-17 2001-08-27 Millennum Pharmaceuticals, Inc. Methods and compositions for the identification, assessment, prevention and therapy of human cancers
US20020081596A1 (en) * 2000-03-24 2002-06-27 James Lillie Compositions and methods for the identification, assessment, prevention, and therapy of human cancers
AU2001251613A1 (en) * 2000-04-14 2001-10-30 Millennum Pharmaceuticals, Inc. Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers
US20020015956A1 (en) * 2000-04-28 2002-02-07 James Lillie Compositions and methods for the identification, assessment, prevention, and therapy of human cancers
US6368806B1 (en) * 2000-10-05 2002-04-09 Pioneer Hi-Bred International, Inc. Marker assisted identification of a gene associated with a phenotypic trait
AU2002318374A1 (en) * 2001-06-21 2003-01-08 Baylor College Of Medicine Prediction, diagnosis and treatment of endocrine resistant breast cancer, using p38 mapk pathway

Also Published As

Publication number Publication date
EP1576177A2 (de) 2005-09-21
EP1576177A4 (de) 2007-12-26
US20040018527A1 (en) 2004-01-29
JP2006505256A (ja) 2006-02-16
AU2003301458A1 (en) 2004-05-04
ZA200409189B (en) 2006-03-29
CA2486105A1 (en) 2004-04-29
WO2004035805A3 (en) 2006-02-16
WO2004035805A2 (en) 2004-04-29
RU2004136990A (ru) 2005-08-10
MXPA04011424A (es) 2005-02-17

Similar Documents

Publication Publication Date Title
GB0403705D0 (en) Gaming facility and method of operation thereof
DE60336405D1 (de) Dreiteilige einwegunterwäsche und herstellungsverfahren dafür
EP1793767A4 (de) Selbsteingeschränkte, segmentierte stents und entwicklungsverfahren dafür
SG113597A1 (en) Method of restoring dimensions of an airfoil and preform for performing same
GB2420261B (en) Processing of graphics
EP1678168A4 (de) Modulatoren von p70s6-kinase und anwendungsverfahren
EP1687789A4 (de) Verfahren zur veröffentlichung und verteilung von bildungsmaterial
EP1542079A4 (de) Beschichtungsbildemittel zur verringerung der musterabmessung und verfahren zur bildung eines feinen musters damit
AU2003299864A8 (en) Sirna compounds and methods for the downregulation of gene expression
GB2419931B (en) Silent chain and method of producing same
AU2003273332A8 (en) Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
IL165240A0 (en) Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemorsistance
GB0404954D0 (en) An aparatus and method for flood defence
GB2435791B (en) Illuminated clipboard and method of use
AU2003261921A1 (en) Resist and method of forming resist pattern
GB2428159B (en) Computer Hologram And Creation Method Thereof
EP1640045A4 (de) Spielmaschine und computersteuerverfahren
TWI316165B (en) Over-coating agent for forming fine patterns and a method of forming fine patterns using such agent
EP1778421A4 (de) Verbesserte reibungsvermindernde fläche und herstellungsverfahren dafür
AU2003272625A8 (en) Mono-column floating platform and method of installing same
AU2003209211A8 (en) Methods and compositions for assaying homocysteine
EP1598440A4 (de) Gasaufkohlungsverfahren
GB0200595D0 (en) Quantitation of differential expression
EP1458404A4 (de) Polyphenol-hemmung der nucleosid-diphosphatkinase-b-aktivität und krebsmetastasen
AU2003298934A8 (en) Method and apparatus for determining gene expression levels